“PHARMACEUTICAL PERFORMANCE IN THE EVALUATION AND ADHERENCE TO PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS”, REMUNOM, vol. 9, no. 1, pp. 1–13, May 2025, doi: 10.61164/rmnm.v9i1.3911.